Wire · founder news, decoded · regulatory
Rescheduling Marijuana: The Bet That May Be About To Go Very Wrong | Newswire
◆ Published
19 July 2026
◆ Topic
regulatory
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 July 2026 · Fusion42 review
The U.S. Court of Appeals for the D.C. Circuit is reviewing the Attorney General's April 2026 Marijuana Rescheduling Order, which moved cannabis to Schedule III and granted tax relief and NYSE listing pathways to multistate operators. The government's own Federal Register admission that formal rulemaking was required—but never conducted—mirrors D.C. Circuit precedent that could vacate the order and force Schedule I status back, erasing gains for Trulieve, Verano, Cresco, and Green Thumb.
◆ The Wire takeaway
If the D.C. Circuit vacates the Rescheduling Order—which its own precedent suggests it will—Trulieve's NYSE listing, Green Thumb's DEA fast-track, and every tax relief claim vanish overnight, leaving these companies back where they started: admittedly breaking federal law. The multistate operators bet on forgiveness; the court is about to ask whether forgiveness was lawfully granted.
◆ Related on Wire
- The FTC After Slaughter: What Businesses Need to Understand | JD Supra11 July 2026
- FDA halts release of new drug rejection letters while working to formalize policy9 July 2026
- FDA plans to release more CRLs as controversial policy resumes16 July 2026
- FTC Consent Order Resolves Antitrust Concerns7 July 2026
- SCOTUS Ruling Calls into Question EU-U.S. Personal Data Flows | JD Supra10 July 2026
- Federal Antitrust Enforcers Entreat State Attorneys General to Jointly Investigate Retail ...16 July 2026
◆ Topics
cannabis-rescheduling · d-c-circuit-challenge · schedule-iii-risk · multistate-operators · section-280e-tax · regulatory-reversal